¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other hyperparathyroidism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® hyperparathyroidism ÇÑ±Û ºÎ°©»ó»ù±â´ÉÇ×ÁøÁõ
¼³¸í   
  ºÎ°©»ó»ù È£¸£¸óÀÇ ºÐºñ°¡ ¸¹¾ÆÁ® Àִ »óŸ¦ ¸»ÇÑ´Ù. ºÎ°©»ó»ù È£¸£¸óÀº Ç÷Áß¿¡ Ä®½·ÀÇ ³óµµ¸¦ ³ôÀ̴ ¿ªÇÒÀ» ÇÑ´Ù. Áï »À¼Ó¿¡ µé¾îÀִ Į½·À» ºÐÇØÇÏ¿© Ç÷ÁßÀ¸·Î ³»º¸³»°í ÄáÆÏ¿¡ ÀÛ¿ëÀ» ÇÏ¿©¼­ ¿ÀÁÜÀ¸·Î Ã¼¿Ü·Î ¹è¼³µÇ´Â Ä®½·ÀÇ ÀçÈí¼ö¸¦ ÃËÁø½ÃŰ°í ¼ÒÈ­°ü¿¡¼­ Ä®½·ÀÇ Èí¼ö¸¦ ÃËÁø½ÃŲ´Ù. ÁַΠºÎ°©»ó¼±ÀÇ ¾Ï¿¡ ÀÇÇÏ¿© ¸¹Àº ºÎ°©»ó¼± È£¸£¸óÀÌ »ý¼ºµÇ´Â °ÍÀÌ ÁÖ ¿øÀÎÀ̰í, ¾ÏÀÇ »ý¼º¾øÀÌ ºÎ°©»ó»ù È£¸£¸óÀ» °ú»ý»êÇϴ °æ¿ìµµ ÀÖ´Ù. ¶§·Î´Â ´Ù¸¥ ¾ÏµéÀÌ ÀÌ ºÎ°©»ó»ùÈ£¸£¸óÀ» ºÐºñÇÏ¿©¼­ ºÎ°©»ó»ù±â´ÉÇ×ÁøÁõÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù. Áõ»óÀº À§Ã¢ÀÚÁõ¼¼(±¸¿ªÁú, ±¸Åä, º¯ºñ, ½Ä¿åºÎÁø), ÁßÃ߽ŰæÁõ¼¼(¹«°ü½É, ¿ì¿ï, ±â¾ï·Â°¨Åð, ÀǽĠȥµ¿), ½Å°æ ±ÙÀ°Áõ¼¼(ÇÇ·Î, ±Ù·ÂÀúÇÏ) µîÀÌ ³ªÅ¸³ª°í °Ë»ç¼Ò°ßÀº Ç÷û Ä®½·ÀÌ »ó½ÂµÇ¾î ÀÖ°í(>12mg/dL), Ç÷û ÀÎÀº °¨¼Ò(<3mg/dL)µÇ¾î ÀÖ´Ù. ÄáÆÏ, Àδ령נ¿¬°ñ µî ¿¬ºÎÁ¶Á÷ÀÇ Ä®½·Ä§ÂøÀ» ÀÏÀ¸Å²´Ù. Ä¡·á´Â ºÎ°©»ó»ùÁ¾ÀÌ ÀÖÀ¸¸é ¿Ü°úÀûÀ¸·Î ¶¼¾î³»°í, ºÎ°©»ó»ù°ú´ÙÇü¼º¿¡ ´ëÇØ¼­´Â ºÎºÐÀýÁ¦¸¦ ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó»ùÇ×ÁøÁõ, ºÎ°©»ó¼±Ç×ÁøÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó»ùÇ×ÁøÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hyperparathyroidism
    ºÎ°©»ó¼±Ç×ÁøÁõ(ÜùË£ßÒàÍùñòäñø)
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ(ÜùË£ßÒàÍѦÒöùñòäñø)
  • hyperparathyroidism =parathyreosis
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • atypical, mixed or other personality
    ºñÁ¤Çü ³»Áö È¥ÀçÇü ¶Ç´Â ±âŸ ÀΰÝ
  • shock and other somatic treatment
    Ãæ°Ý ¹× ±âŸ ½Åüġ·á
  • brown tumor, hyperparathyroidism
    °¥»öÁ¾¾ç, ºÎ°©»ó¼±±â´É Ç×ÁøÁõ(ÜùË£ßÒàÍѦÒö ùñòäñø)
  • ectopic hyperparathyroidism
    À̼Ҽº ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ.
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ
  • hyperparathyroidism
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ(ÜùË£ßÒàÍѦÒöùñòäñø)
  • hyperparathyroidism =parathyreosis
    ºÎ°©»ó¼±±â´ÉÇ×ÁøÁõ.
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(¼Ó¹ß¼ººÎ°©»ó ¼±±â´ÉÇ×ÁøÁõ).
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(áÙÛ¡àõÜùË£ßÒ àÍѦÒöùñòäñø).
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(áÙÛ¡àõÜùË£ßÒàÍѦÒöùñòäñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperparathyroidism
    ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
HPT histamine provocation test; human placental thyrotropin; hyperparathyroidism; hypothalamo-pituitary-...
HRPT hyperparathyroidism
NSHPT neonatal severe hyperparathyroidism
NSPH neonatal severe hyperparathyroidism
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DRO Differential Reinforcement of Other Behaviour
MOTT Mycobacteria Other Than Tuberculosis
OND Other Neurological Diseases
SO significant other
AOD and other drug
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • E21.2
    Other hyperparathyroidism
    ±âŸ ºÎ°©»ó»ù ±â´ÉÇ×ÁøÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ectopic hyperparathyroidism
    À̼Ҽº ºÎ°©»ó¼± ±â´ÉÇ×ÁøÁõ
  • hyperparathyroidism
    ºÎ°©»ó¼± ±â´É Ç×ÁøÁõ
    µ¿ÀǾî=
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×Áø, ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´É Ç×ÁøÁõ
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • other abnormality
    ±âŸ ÀÌ»ó
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • other facial structure
    ´Ù¸¥ ¾È¸é ±¸Á¶¹°
  • other mycoses
    ±âŸ Áø±ÕÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
other-directed Pertaining to a person readily influenced by the attitudes of others.
(05 Mar 2000)
transferases (other substituted phosphate groups) <enzyme> A class of enzymes that transfers substituted phosphate groups.
Registry number: EC 2.7.8
(12 Dec 1998)
primary hyperparathyroidism Hyperparathyroidism due to neoplasms or idiopathic hyperplasia of the parathyroid glands.
(05 Mar 2000)
secondary hyperparathyroidism Hyperparathyroidism that arises as a result of disordered metabolism producing hypocalcaemia, as in chronic uraemia due to renal disease, malabsorption, rickets, or osteomalacia; associated with hyperplasia of the parathyroid glands.
(05 Mar 2000)
hyperparathyroidism The over production of parathormone by the parathyroid glands. Usually secondary to an adenoma (an unregulated glandular tumour that produces parathormone in an increased quantity). Laboratory studies show an elevated calcium in the blood. most patients are without symptoms. Symptoms in more advanced cases include lethargy, confusion, nausea, bone pain and weakness. Findings include hypertension and slow heart rate. Complications include pancreatitis, peptic ulcer disease and kidney stones.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • each other
    ¼­·Î
  • in some way or other
    ¾î¶»°Ô ÇØ¼­µçÁö
  • other
    ±×¹ÛÀÇ
  • some other time
    ¾ðÁ¨°¡ µý³¯¿¡(=some other day)
  • t'other
    ¶Ç Çϳª
  • A.N. Other
    ÀÍ¸í¾¾;¼±¼ö ¹ÌÁ¤
  • other
    µý;´Ù¸¥;´ÙÀ½ÀÇ;³ª¸ÓÁöÀÇ;every ~ Çϳª°É·¯;none ~ than ´Ù¸§ ¾Æ´Ñ;the ~ day(night)ÀÏÀü(¿äÀü³¯ ¹ã)¿¡;the ~ party »ó´ë¹æ;the ~ side (¹Ì±¹¿¡¼­ º») À¯·´;the ~ world ³»¼¼;Àú½Â
  • other
    ±×·¸Áö ¾Ê°í;µý ¹æ¹ýÀ¸·Î
  • other
    µý °Í(»ç¶÷);´Ù¸¥ Çϳª;³ª¸ÓÁö °Í;of all ~s ¸ðµç °Í(»ç¶÷)Áß¿¡¼­ ƯÈ÷;some ... or ~ ¹«¾ð(´©±º,¾îµò)°¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á